Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine

Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine


Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 Thursday, a week and a half after his initial diagnosis, in what his doctors say is a case of rebound infection.

Martin Ollman | Getty Images News | Getty Images

SINGAPORE — Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 a week and a half after his initial diagnosis, in what his doctors said is a case of rebound infection.

“I feel fine but I am afraid I have turned COVID-19 positive again,” Lee said Thursday on social media. “My doctors say it is a Covid rebound, which happens in 5-10% of cases. It is still infectious although the risk is not high compared to the initial infection.”

As a result, Lee missed the consecration ceremony of a Hindu temple in Singapore. His reinfection comes as Singapore prepares to host top defense leaders from Asia Pacific at this weekend’s Shangri-La Dialogue, including China defense minister, Gen. Li Shangfu, U.S. Secretary of Defense Lloyd Austin and Australian Prime Minister Anthony Albanese.

Lee, who is 71-years-old, was prescribed the antiviral medication Paxlovid when he first tested positive on May 22 after returning from a six-day official working trip to South Africa and Kenya. He has been serving as prime minister of the Southeast Asian city-state since 2004.

Singapore is coming off an April peak in Covid-19 infections and its government has been lauded for its largely effective handling of the pandemic.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More